Jun 13, 2023 / 05:00PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
This morning. I'm Matt Sykes, the life sciences tools and diagnostics analyst at Goldman Sachs. It's a pleasure to welcome Bob McMahon, CFO of Agilent to the stage today. Bob, thank you very much for coming.
Robert W. McMahon - Agilent Technologies, Inc. - Senior VP & CFO
Thank you. It's a pleasure to be here.
Questions and Answers:
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research AnalystGreat. Maybe I'll let you kind of set the stage first and talk about your most recent results and sort of trends you're seeing in your business as we enter the second half of this year.
Robert W. McMahon - Agilent Technologies, Inc. - Senior VP & CFO
Yes. We -- through the first half of the year, we're actually very pleased with the performance of the company. We actually had very solid results in the second quarter, 9.5% core growth and actually 12%
Trustpilot
